121 related articles for article (PubMed ID: 28454738)
1. Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.
Miksys S; Wadji FB; Tolledo EC; Remington G; Nobrega JN; Tyndale RF
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():140-148. PubMed ID: 28454738
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
Dhingra D; Goswami S; Gahalain N
Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate.
Egan MF; Ferguson JN; Hyde TM
Brain Res Bull; 1995; 38(4):355-63. PubMed ID: 8535858
[TBL] [Abstract][Full Text] [Related]
4. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
Bordia T; McIntosh JM; Quik M
J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
[TBL] [Abstract][Full Text] [Related]
5. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol versus risperidone on rat "early onset" vacuous chewing.
Marchese G; Bartholini F; Casu MA; Ruiu S; Casti P; Congeddu E; Tambaro S; Pani L
Behav Brain Res; 2004 Feb; 149(1):9-16. PubMed ID: 14739005
[TBL] [Abstract][Full Text] [Related]
7. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
[TBL] [Abstract][Full Text] [Related]
8. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
9. Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia.
McMillan DM; Miksys S; Tyndale RF
Addict Biol; 2019 Mar; 24(2):228-238. PubMed ID: 29266563
[TBL] [Abstract][Full Text] [Related]
10. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Hyde TM; Egan MF; Wing LL; Wyatt RJ; Weinberger DR; Kleinman JE
Psychopharmacology (Berl); 1995 Mar; 118(2):142-9. PubMed ID: 7617800
[TBL] [Abstract][Full Text] [Related]
11. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
McMillan DM; Tyndale RF
Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.
de Araújo DP; Camboim TGM; Silva APM; Silva CDF; de Sousa RC; Barbosa MDA; Oliveira LC; Cavalcanti JRLP; Lucena EES; Guzen FP
Can J Physiol Pharmacol; 2017 Jul; 95(7):837-843. PubMed ID: 28329449
[TBL] [Abstract][Full Text] [Related]
13. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
[TBL] [Abstract][Full Text] [Related]
14. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
15. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
McMillan DM; Tyndale RF
Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
[TBL] [Abstract][Full Text] [Related]
16. Influence of magnesium supplementation on movement side effects related to typical antipsychotic treatment in rats.
Kronbauer M; Metz VG; Roversi K; Dias VT; de David Antoniazzi CT; da Silva Barcelos RC; Burger ME
Behav Brain Res; 2017 Mar; 320():400-411. PubMed ID: 27816557
[TBL] [Abstract][Full Text] [Related]
17. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
18. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
Bachus SE; Yang E; McCloskey SS; Minton JN
Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
[TBL] [Abstract][Full Text] [Related]
19. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
20. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
